A field manual for the moment when birch-bark triterpenes, plant omega esters and lecithin agree to behave as one organ — and a quiet oleogel becomes a targeted treatment for equine melanoma.
The melanoma gel is not a single substance. It is a quartet — triterpene fraction, omega-ester carrier, lecithin matrix and castor-oil scaffold — that only becomes therapeutic when the four phases agree to behave as one.
Each phase has a job. The triterpenes act. The omega esters carry. The lecithin encapsulates. The castor oil holds geometry. Below — the bed before the cure.
The active warhead. A natural co-equilibrium of pentacyclic lupanes and oleananes extracted from birch outer bark — selectively cytotoxic toward melanocytic tumour cells via the mitochondrial apoptosis pathway.
Plant-derived α-linolenic, linoleic and oleic acids — delivered as ethyl and glyceryl esters. They solubilise the triterpenes, plasticise the gel and pre-condition the skin barrier for triterpene entry.
Plant lecithin self-assembles around the lipid-soluble actives, producing liposome-like carriers. This is the structural key that turns a simple oil mix into a transdermal delivery system.
The viscous, hydroxyl-bearing scaffold. Provides the body of the gel, wets equine skin, and gives the omega·lecithin phase the geometry it needs to set without separating.
Hydrolysed remnants of the omega and castor phases — ricinoleic, oleic, azelaic. Mildly antimicrobial, surfactant-like, and themselves active around lesions.
Antioxidant guardian. Protects the polyunsaturated omega esters and the triterpene fraction against autoxidation — without it, the matrix would not survive months on the shelf.
Triterpenes, omega esters and lecithin do not simply coexist — they self-assemble into vesicles that carry the entire pharmacology across the equine skin barrier in a single object.
Betulinic acid, betulin and lupeol are extracted into castor oil and the omega 3·6·9 ester phase. Lipophilic, potent — but unable to cross a hydrophilic skin barrier on their own.
BA + Betulin + Lupeol → oleogel suspensionPlant phosphatidylcholine is dispersed into the warm castor·omega-ester mixture. The amphiphilic heads orient toward residual water, the tails point inward — a sheet emerges.
PC + oleogel → bilayer sheetUnder mechanical shear the bilayer curls around droplets of the triterpene-loaded oil. The system minimises its surface energy by closing into spheres.
shear → bilayer curvature → enclosureA stable phospholipid vesicle now carries the entire triterpene-omega payload — protected from oxidation, primed for transdermal delivery.
→ multilamellar liposome ⊃ {BA, Betulin, ω-3·6·9}Phosphatidylcholine in the vesicle fuses with the tumour-cell membrane. Betulinic acid is released directly into the lipid bilayer of melanoma cells, bypassing systemic distribution.
vesicle ∪ cell membrane → intracellular BAThe gel is not one molecule. It is a population of triterpenes, fatty-acid esters, phospholipids and trace co-actives, each with a defined role in the delivery of betulinic acid to melanoma cells.
A simulated cross-section of the gel. Gold spheres are triterpene-bearing liposomes. Bio-green motes are omega-3·6·9 ester carriers. Rouge sparks are betulinic-acid molecules in transit. Move your cursor — the matrix follows.
Stored quietly as a phospholipid oleogel, the chemistry only becomes pharmacological at the lesion — once the lecithin vesicle fuses with the melanoma membrane, a stepped cascade unfolds.
The vault. A multilamellar vesicle of plant phosphatidylcholine carrying betulinic acid, betulin and the omega ester fraction in protected form.
PC heads on the vesicle align with PC heads on the tumour-cell membrane. Bilayers merge. The triterpene payload is deposited directly into the lipid leaflet.
Betulinic acid migrates to the mitochondrial outer membrane. It opens the permeability transition pore — cytochrome c is released.
The caspase cascade is initiated. Melanoma cells die in a controlled, non-inflammatory way. Surrounding healthy tissue, lacking the same membrane composition, is left intact.
Equine melanocytic tumour cells share the same chemistry the gel attacks — unsaturated phospholipid membranes and a heightened mitochondrial sensitivity. The gel acts like-with-like: a phospholipid carrier finds a phospholipid membrane and the inside falls open.
Betulinic acid acts at the mitochondrial outer membrane of melanoma cells, triggering pore opening and cytochrome-c release — the textbook intrinsic apoptosis pathway.
Phosphatidylcholine vesicles fuse with the lipid-rich tumour membrane. The active is deposited inside the cell — not absorbed systemically.
Lupeol and oleanolic acid quiet the NF-κB inflammation around the lesion. Omega-3 ester precursors feed the resolving lipid mediators.
Normal equine skin cells lack the membrane composition and mitochondrial fragility of the tumour — the gel passes through them without provoking apoptosis.
"What looks like an oil is, in fact, a slow ecosystem — a population of triterpenes, phospholipid vesicles and omega-ester carriers quietly negotiating with the air above the meniscus. The gel is not a product. It is a chemistry that has agreed to be still until it isn't."